![]() |
Open for inclusion |
Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma (B-CAP)Cancer type: Lymphoma Phase: II Principal Investigator: Joergensen Judit Country: DK Keywords: Denmark, Aarhus, Århus, Hodgkin lymphoma Status: Open for inclusion Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02191930 |